MAJOR — Use With Caution
FDA lamotrigine label requires specific slower dose titration and lower target doses when used with valproate. Risk of Stevens-Johnson syndrome is increased.
Evidence level: STRONG
Valproic acid (Depakote) dramatically slows how your body eliminates lamotrigine (Lamictal), which can double lamotrigine levels. This significantly increases the risk of a serious, potentially life-threatening skin rash called Stevens-Johnson syndrome.
Valproic acid inhibits glucuronidation (UGT1A4), the primary elimination pathway of lamotrigine. Doubles lamotrigine half-life and levels. Increases risk of serious skin reactions (Stevens-Johnson syndrome). FDA lamotrigine label requires dose reduction with valproate.
If you take both medications, your lamotrigine dose should be roughly half of what it would be without valproate. Dose increases must be very gradual. Report ANY rash immediately.
Multiple antiepileptics is common for refractory epilepsy. Maintain exact timing consistency — even small blood level fluctuations can trigger breakthrough seizures. Many antiepileptics are strong enzyme inducers/inhibitors that affect each other's levels. Your neurologist should monitor drug levels regularly.
Higher risk for: those on multiple antiepileptics (enzyme induction/inhibition), liver impairment, elderly, pregnant individuals (teratogenicity concerns), or those with recent dose changes.
Skin rash (can start as small spots and spread rapidly), fever, flu-like symptoms, blistering of skin or mucous membranes, mouth sores, eye inflammation — seek emergency care for any rash
Follow FDA-recommended lamotrigine titration schedule for patients on valproate (starting dose 25mg every other day, very slow increases). Any rash requires immediate evaluation.
Antiepileptic drug levels are sensitive to enzyme inducers and inhibitors. Discuss any changes with your neurologist before adding new substances. Safer supplement options: magnesium, omega-3s, and B vitamins are generally well-tolerated alongside seizure medications.
Valproic acid (Depakote) dramatically slows how your body eliminates lamotrigine (Lamictal), which can double lamotrigine levels. This significantly increases the risk of a serious, potentially life-threatening skin rash called Stevens-Johnson syndrome.
Multiple antiepileptics is common for refractory epilepsy. Maintain exact timing consistency — even small blood level fluctuations can trigger breakthrough seizures. Many antiepileptics are strong enzyme inducers/inhibitors that affect each other's levels. Your neurologist should monitor drug levels regularly.
Skin rash (can start as small spots and spread rapidly), fever, flu-like symptoms, blistering of skin or mucous membranes, mouth sores, eye inflammation — seek emergency care for any rash
Antiepileptic drug levels are sensitive to enzyme inducers and inhibitors. Discuss any changes with your neurologist before adding new substances. Safer supplement options: magnesium, omega-3s, and B vitamins are generally well-tolerated alongside seizure medications.
Follow FDA-recommended lamotrigine titration schedule for patients on valproate (starting dose 25mg every other day, very slow increases). Any rash requires immediate evaluation.
Or browse the full interaction database (121,000+ pairs).